|
The BioIndustry Association (BIA) and Medicines and Healthcare products Regulatory Agency (MHRA) are delighted to announce that registration is now open and the programme is available for the sixth joint regulatory conference on ‘Accelerated Development and Access to Innovative Medicines for Patients’ taking place on Wednesday 4 May 2016.
Programme confirmed
This one-day conference is an established fixture in the regulatory arena and offers attendees excellent value for money and is a must-attend event.
An impressive line-up of speakers are confirmed:
We are delighted to have Sir Hugh Taylor, Independent Chair, Accelerated Access Review and Professor Sir John Bell, Chair, Accelerated Access Review’s Expert Advisory Group providing keynote presentations.
Joining these keynote speakers will be senior experts and leading speakers from the MHRA, the European Medicines Agency (EMA), the life science industry, the NHS, NICE, investment firms and patient organisations including:
-
Dr Ian Hudson, Chief Executive, Medicines and Healthcare products Regulatory Agency
-
Alan Morrison, Chairman, BIA Regulatory Affairs Advisory Committee, and VP Regulatory Affairs International, MSD
-
Malcolm Qualie, Pharmacy Lead, Specialised Services, NHS England
-
Dr Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health and Care Excellence (NICE)
-
Dr Eliot Forster, Chief Executive Officer, Immunocore
-
Robert Hemmings, Manager, Licensing Division, MHRA, and Chair, CHMP’s Scientific Advice Working Party, EMA
-
Jordi Llinares, Head of Product Development Scientific Support Department, EMA
-
Dr Joep Muijrers, Partner, LSP (Life Science Partners)
Plus many more. See who else is speaking here.
The conference is structured with a mix of presentations and engaging panel discussions on a wide-range of topics including:
- Innovation and accelerated access in the UK – Where are we today?
- The Early Access to Medicines Scheme (EAMS): Two years on
- Adaptive pathways
- The new EMA’s PRIME (Priority Medicines) scheme
- Benefits of accelerated assessment in the EU
View the full programme and more details on the conference website and reserve your place today
|
Venue
Royal Society of Medicine
One Wimpole Street
London
W1G 0AE
Date
Wednesday 4 May 2016
Time
9.00 - 17.30
Fees
BIA Member: £395.00 + VAT
MHRA Contact: £395.00 + VAT
Non Member: £525.00 + VAT
Academic/NHS: £195.00 + VAT
Charity/NFP: £195.00 + VAT
Network Member: £195.00 + VAT
|
